Knight Therapeutics Initiates Legal Action Against Medison Biotech to Protect the Interests of Knight Shareholders
MONTREAL, March 21, 2019 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a Canadian specialty pharmaceutical company, today announced that it has initiated a lawsuit in District Court Center-Lod in Israel against Medison …